Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] was reported 49143 times

Drugs of the Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PINEALOBLASTOMA 76 0.8172
1 GENOTYPE DRUG RESISTANCE TEST 39 0.7959
2 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 102 0.7907
3 CSF HIV ESCAPE SYNDROME 83 0.6014
4 HIV VIRAEMIA 122 0.5810
5 ULTRASOUND ANTENATAL SCREEN 54 0.5625
6 VIRAL MUTATION IDENTIFIED 1889 0.5123
7 IMMUNE RECONSTITUTION SYNDROME 652 0.5050
8 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 122 0.4388
9 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 46 0.4144
10 VIROLOGIC FAILURE 2168 0.4027
11 TOTAL LUNG CAPACITY INCREASED 103 0.3787
12 BLOOD HIV RNA INCREASED 595 0.3278
13 HEPATITIS B DNA INCREASED 207 0.3071
14 LIPODYSTROPHY ACQUIRED 652 0.3068
15 MITOCHONDRIAL TOXICITY 251 0.3057
16 DANDY-WALKER SYNDROME 70 0.2703
17 BIRTH MARK 56 0.2692
18 BONE DEMINERALISATION 248 0.2342
19 PATHOGEN RESISTANCE 2035 0.2230
20 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 74 0.2209
21 MITOCHONDRIAL CYTOPATHY 96 0.2182
22 KAPOSI'S SARCOMA 103 0.2052
23 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 105 0.2008
24 FANCONI SYNDROME ACQUIRED 329 0.1873
25 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 849 0.1702
26 HEPATITIS B REACTIVATION 532 0.1675
27 CD4 LYMPHOCYTES INCREASED 39 0.1674
28 CONGENITAL UMBILICAL HERNIA 61 0.1635
29 HEPATITIS B SURFACE ANTIGEN POSITIVE 42 0.1533
30 MACROCEPHALY 58 0.1495
31 MITOCHONDRIAL MYOPATHY 32 0.1468
32 HEPATITIS B 865 0.1434
33 CHORIOAMNIONITIS 27 0.1421
34 LIPOATROPHY 135 0.1418
35 MENINGOMYELOCELE 84 0.1400
36 NEUTROPENIA NEONATAL 31 0.1384
37 FACIAL WASTING 37 0.1375
38 GENOTYPE DRUG RESISTANCE TEST POSITIVE 136 0.1323
39 OSTEOMALACIA 198 0.1281
40 VIRAL LOAD INCREASED 490 0.1261
41 TRISOMY 18 47 0.1234
42 POLYDACTYLY 141 0.1216
43 ACQUIRED IMMUNODEFICIENCY SYNDROME 63 0.1214
44 FANCONI SYNDROME 170 0.1201
45 CD4 LYMPHOCYTES DECREASED 252 0.1176
46 MONKEYPOX 32 0.1159
47 ACQUIRED GENE MUTATION 149 0.1137
48 RENAL TUBULAR DYSFUNCTION 64 0.1133
49 HIV INFECTION 336 0.1114
50 CHRONIC HEPATITIS B 35 0.1104
51 HYPOPHOSPHATAEMIC OSTEOMALACIA 29 0.1098
52 ACUTE HEPATITIS B 36 0.1084
53 HYPOURICAEMIA 31 0.1069
54 TRISOMY 21 134 0.1063
55 CONGENITAL HYDROCEPHALUS 53 0.1045
56 STILLBIRTH 492 0.1017
57 ANAEMIA NEONATAL 49 0.1017
58 HYDROPS FOETALIS 62 0.1011
59 SYPHILIS 73 0.1004
60 FOETAL EXPOSURE DURING DELIVERY 63 0.0929
61 NEURAL TUBE DEFECT 67 0.0922
62 MENINGITIS CRYPTOCOCCAL 161 0.0920
63 PLAGIOCEPHALY 44 0.0882
64 DRUG RESISTANCE 2228 0.0866
65 VIRAEMIA 119 0.0859
66 NODULAR REGENERATIVE HYPERPLASIA 55 0.0857
67 EXOMPHALOS 45 0.0838
68 CUSHING'S SYNDROME 58 0.0835
69 PSYCHIATRIC DECOMPENSATION 161 0.0823
70 ATRIOVENTRICULAR SEPTAL DEFECT 38 0.0809
71 LIPOHYPERTROPHY 50 0.0804
72 MULTIPLE-DRUG RESISTANCE 230 0.0741
73 INTRA-UTERINE DEATH 116 0.0722
74 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 78 0.0721
75 MENINGITIS TUBERCULOUS 39 0.0698
76 CEREBRAL TOXOPLASMOSIS 65 0.0696
77 GASTROSCHISIS 33 0.0693
78 PORTAL HYPERTENSIVE GASTROPATHY 39 0.0691
79 MALARIA 48 0.0681
80 HYPERLACTACIDAEMIA 179 0.0667
81 CYTOMEGALOVIRUS CHORIORETINITIS 130 0.0666
82 GENE MUTATION 129 0.0651
83 CONGENITAL FOOT MALFORMATION 28 0.0617
84 RETINAL TOXICITY 63 0.0612
85 FOETAL GROWTH RETARDATION 47 0.0600
86 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 28 0.0600
87 ANAEMIA MACROCYTIC 127 0.0595
88 PORTAL HYPERTENSION 183 0.0593
89 CONGENITAL HYDRONEPHROSIS 42 0.0587
90 GLYCOSURIA 79 0.0584
91 EAR MALFORMATION 27 0.0583
92 RENAL TUBULAR DISORDER 163 0.0579
93 ANHEDONIA 1456 0.0554
94 CRYPTOCOCCOSIS 90 0.0552
95 UMBILICAL CORD ABNORMALITY 29 0.0550
96 NEONATAL DISORDER 87 0.0549
97 NEURODEVELOPMENTAL DISORDER 37 0.0547
98 ARNOLD-CHIARI MALFORMATION 52 0.0545
99 DEATH NEONATAL 74 0.0532
100 BLOOD LACTIC ACID INCREASED 280 0.0531
101 VISCERAL LEISHMANIASIS 38 0.0526
102 LYMPH NODE TUBERCULOSIS 39 0.0524
103 ALPHA 1 FOETOPROTEIN INCREASED 37 0.0520
104 HIV TEST POSITIVE 34 0.0514
105 FOETAL DEATH 266 0.0512
106 PSYCHOMOTOR SKILLS IMPAIRED 134 0.0511
107 PREMATURE RUPTURE OF MEMBRANES 123 0.0510
108 BLOOD BILIRUBIN UNCONJUGATED INCREASED 37 0.0510
109 DRUG EXPOSURE DURING PREGNANCY 1708 0.0502
110 CLEFT LIP AND PALATE 56 0.0501
111 SKULL MALFORMATION 32 0.0498
112 HEPATITIS A 42 0.0495
113 OPHTHALMOPLEGIA 77 0.0488
114 PLACENTAL DISORDER 46 0.0486
115 CRYPTORCHISM 54 0.0481
116 TEMPERATURE REGULATION DISORDER 105 0.0471
117 HYPERTRIGLYCERIDAEMIA 274 0.0468
118 ABORTION INDUCED 435 0.0462
119 DYSLIPIDAEMIA 233 0.0458
120 HEPATIC FIBROSIS 153 0.0445
121 MACROCYTOSIS 51 0.0440
122 PYELOCALIECTASIS 42 0.0438
123 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 38 0.0435
124 JAUNDICE CHOLESTATIC 153 0.0433
125 SPINA BIFIDA 90 0.0432
126 MYCOBACTERIUM AVIUM COMPLEX INFECTION 115 0.0428
127 VARICES OESOPHAGEAL 125 0.0413
128 DEPRESSIVE SYMPTOM 145 0.0411
129 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 45 0.0409
130 HEPATOSPLENOMEGALY 105 0.0409
131 CEREBRAL VENTRICLE DILATATION 47 0.0408
132 HYPOMANIA 149 0.0405
133 TOXOPLASMOSIS 43 0.0398
134 OESOPHAGEAL VARICES HAEMORRHAGE 86 0.0396
135 PNEUMOCYSTIS JIROVECI PNEUMONIA 86 0.0386
136 RENAL TUBULAR ACIDOSIS 83 0.0380
137 FAT TISSUE INCREASED 55 0.0379
138 LIVE BIRTH 315 0.0376
139 PLACENTAL INSUFFICIENCY 30 0.0374
140 ECONOMIC PROBLEM 566 0.0373
141 DEPRESSION SUICIDAL 128 0.0369
142 TWIN PREGNANCY 31 0.0369
143 LIMB MALFORMATION 29 0.0368
144 OSTEOPENIA 557 0.0367
145 HYDROCELE 39 0.0366
146 VANISHING BILE DUCT SYNDROME 40 0.0359
147 HYPOPHOSPHATAEMIA 265 0.0358
148 BLOOD AMYLASE INCREASED 61 0.0356
149 PULMONARY TUBERCULOSIS 152 0.0355
150 FOETAL EXPOSURE DURING PREGNANCY 2841 0.0349
151 CAESAREAN SECTION 404 0.0347
152 POLYHYDRAMNIOS 35 0.0343
153 BONE MARROW TOXICITY 40 0.0338
154 TEARFULNESS 143 0.0332
155 MYCOBACTERIAL INFECTION 56 0.0325
156 HISTOPLASMOSIS 57 0.0322
157 FOETAL DISTRESS SYNDROME 68 0.0320
158 EXPOSURE DURING BREAST FEEDING 106 0.0320
159 MICROCEPHALY 41 0.0320
160 CALCULUS URINARY 49 0.0318
161 HYPOSPADIAS 65 0.0312
162 FOETAL GROWTH RESTRICTION 187 0.0307
163 PORTAL VEIN THROMBOSIS 99 0.0306
164 VENTRICULAR SEPTAL DEFECT 174 0.0304
165 FOETAL HEART RATE ABNORMAL 28 0.0302
166 NEPHRITIS INTERSTITIAL 38 0.0300
167 TALIPES 92 0.0296
168 SMALL FOR DATES BABY 147 0.0296
169 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 31 0.0292
170 MATERNAL DRUGS AFFECTING FOETUS 224 0.0292
171 CYTOLYTIC HEPATITIS 94 0.0283
172 PREMATURE BABY 851 0.0282
173 PREMATURE SEPARATION OF PLACENTA 43 0.0279
174 NON-HODGKIN'S LYMPHOMA 36 0.0275
175 PREMATURE LABOUR 152 0.0269
176 PRE-ECLAMPSIA 127 0.0267
177 HEPATORENAL SYNDROME 45 0.0266
178 VOLVULUS 63 0.0266
179 ATYPICAL MYCOBACTERIAL INFECTION 37 0.0261
180 LOW BIRTH WEIGHT BABY 206 0.0259
181 NEPHROPATHY TOXIC 291 0.0259
182 HEPATOCELLULAR CARCINOMA 194 0.0255
183 HEPATIC NEOPLASM MALIGNANT 54 0.0255
184 PREGNANCY ON CONTRACEPTIVE 37 0.0253
185 CARDIAC MURMUR 219 0.0253
186 HYPOPROTEINAEMIA 48 0.0253
187 NECROTISING COLITIS 32 0.0252
188 LYMPHADENITIS 61 0.0252
189 RHINITIS ALLERGIC 112 0.0251
190 OESOPHAGEAL CANDIDIASIS 98 0.0246
191 LIVER TRANSPLANT REJECTION 44 0.0245
192 DISSEMINATED TUBERCULOSIS 62 0.0241
193 ABORTION SPONTANEOUS 964 0.0240
194 CACHEXIA 123 0.0239
195 BLOOD PHOSPHORUS DECREASED 87 0.0238
196 BLOOD BICARBONATE DECREASED 45 0.0237
197 LIVER TRANSPLANT 84 0.0231
198 HEPATIC ENCEPHALOPATHY 215 0.0230
199 SARCOIDOSIS 109 0.0229
200 DYSMORPHISM 54 0.0229
201 STRONGYLOIDIASIS 37 0.0229
202 OSTEOPOROSIS 940 0.0228
203 NORMAL NEWBORN 124 0.0228
204 HYPERBILIRUBINAEMIA 232 0.0224
205 ATRIAL SEPTAL DEFECT 186 0.0222
206 OPPORTUNISTIC INFECTION 41 0.0222
207 EYELID PTOSIS 225 0.0221
208 HEPATOMEGALY 217 0.0221
209 HYPERPHOSPHATAEMIA 47 0.0218
210 SPEECH DISORDER DEVELOPMENTAL 62 0.0216
211 HEPATITIS E 34 0.0215
212 POSTPARTUM HAEMORRHAGE 29 0.0215
213 BONE DENSITY DECREASED 672 0.0214
214 EXPOSURE DURING PREGNANCY 1333 0.0214
215 NASAL POLYPS 105 0.0213
216 GLUCOSE URINE PRESENT 27 0.0212
217 RENAL COLIC 48 0.0212
218 NEONATAL RESPIRATORY DISTRESS SYNDROME 75 0.0212
219 PATENT DUCTUS ARTERIOSUS 84 0.0211
220 HEPATOTOXICITY 466 0.0209
221 GENITAL HERPES 32 0.0209
222 PREGNANCY 408 0.0204
223 SCHIZOPHRENIA 242 0.0199
224 OSTEOPOROTIC FRACTURE 38 0.0198
225 OPTIC NEUROPATHY 42 0.0198
226 END STAGE RENAL DISEASE 359 0.0197
227 HEPATITIS FULMINANT 58 0.0195
228 BLOOD BILIRUBIN INCREASED 522 0.0193
229 PSYCHOMOTOR RETARDATION 54 0.0192
230 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 157 0.0190
231 HEPATITIS C 229 0.0189
232 HEPATIC FAILURE 569 0.0189
233 HEPATIC NECROSIS 71 0.0188
234 BILIRUBIN CONJUGATED INCREASED 44 0.0188
235 HYPERPARATHYROIDISM SECONDARY 47 0.0187
236 PROTEINURIA 356 0.0187
237 PREMATURE DELIVERY 296 0.0186
238 OPTIC ATROPHY 30 0.0184
239 STRABISMUS 54 0.0184
240 CEREBELLAR SYNDROME 40 0.0182
241 HYDROCEPHALUS 99 0.0182
242 ECTOPIC PREGNANCY 54 0.0175
243 HYPERURICAEMIA 72 0.0175
244 BRONCHIECTASIS 118 0.0175
245 HEPATIC CIRRHOSIS 323 0.0172
246 HYPERLIPIDAEMIA 205 0.0171
247 CUSHINGOID 55 0.0171
248 HYPERPARATHYROIDISM 35 0.0170
249 HEPATITIS CHOLESTATIC 102 0.0169
250 TREATMENT NONCOMPLIANCE 924 0.0169
251 HAEMANGIOMA 39 0.0169
252 OLIGOHYDRAMNIOS 56 0.0168
253 CONGENITAL ANOMALY 129 0.0166
254 SPLENOMEGALY 194 0.0165
255 JAUNDICE 445 0.0165
256 HEPATITIS TOXIC 42 0.0161
257 CHRONIC KIDNEY DISEASE 1217 0.0160
258 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 52 0.0157
259 GESTATIONAL DIABETES 75 0.0157
260 BRAIN HERNIATION 47 0.0157
261 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 51 0.0157
262 HEPATITIS 401 0.0157
263 PROTEIN URINE PRESENT 78 0.0156
264 NEPHROPATHY 145 0.0155
265 OCULAR ICTERUS 67 0.0154
266 APLASIA PURE RED CELL 53 0.0154
267 MULTIPLE FRACTURES 246 0.0150
268 LIPIDS INCREASED 30 0.0149
269 GRANULOMA 51 0.0147
270 HEART DISEASE CONGENITAL 52 0.0147
271 CLEFT PALATE 28 0.0145
272 RENAL TRANSPLANT 52 0.0144
273 FOOD ALLERGY 110 0.0142
274 LIPASE INCREASED 109 0.0142
275 RENAL IMPAIRMENT 1193 0.0142
276 ALANINE AMINOTRANSFERASE INCREASED 871 0.0142
277 DRUG INTERACTION 2193 0.0138
278 LACTIC ACIDOSIS 446 0.0138
279 TREATMENT FAILURE 1131 0.0136
280 EMOTIONAL DISTRESS 1636 0.0135
281 CHOLESTATIC LIVER INJURY 30 0.0135
282 ASCITES 390 0.0133
283 ASPARTATE AMINOTRANSFERASE INCREASED 699 0.0131
284 ENCEPHALITIS 91 0.0131
285 BLOOD CREATININE INCREASED 856 0.0131
286 TRANSAMINASES INCREASED 289 0.0130
287 DRUG-INDUCED LIVER INJURY 405 0.0129
288 DECREASED ACTIVITY 139 0.0129
289 QUALITY OF LIFE DECREASED 172 0.0128
290 HYPOALBUMINAEMIA 99 0.0127
291 PSYCHOTIC DISORDER 375 0.0127
292 BLOOD URIC ACID INCREASED 73 0.0126
293 GLOMERULAR FILTRATION RATE DECREASED 155 0.0126
294 GAMMA-GLUTAMYLTRANSFERASE INCREASED 278 0.0125
295 CREATININE RENAL CLEARANCE DECREASED 50 0.0125
296 HISTIOCYTOSIS HAEMATOPHAGIC 37 0.0124
297 AREFLEXIA 33 0.0124
298 MATERNAL EXPOSURE DURING PREGNANCY 1097 0.0123
299 RENAL TUBULAR NECROSIS 119 0.0121
300 ORAL CANDIDIASIS 158 0.0120
301 PARADOXICAL DRUG REACTION 44 0.0119
302 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 28 0.0119
303 BLOOD ALKALINE PHOSPHATASE INCREASED 294 0.0118
304 OSTEONECROSIS 385 0.0117
305 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 562 0.0117
306 ACUTE LYMPHOCYTIC LEUKAEMIA 33 0.0116
307 ACUTE HEPATIC FAILURE 158 0.0116
308 HYPERTONIA 66 0.0115
309 LUNG NEOPLASM 49 0.0115
310 STEVENS-JOHNSON SYNDROME 254 0.0114
311 LYMPHADENOPATHY 403 0.0114
312 VITAMIN D DEFICIENCY 110 0.0113
313 CONGESTIVE CARDIOMYOPATHY 47 0.0113
314 BLOOD LACTATE DEHYDROGENASE INCREASED 178 0.0112
315 TRANSPLANT REJECTION 88 0.0110
316 BK VIRUS INFECTION 37 0.0110
317 MIXED LIVER INJURY 33 0.0110
318 HYDRONEPHROSIS 82 0.0109
319 ATTENTION DEFICIT HYPERACTIVITY DISORDER 46 0.0109
320 BONE LOSS 162 0.0108
321 PNEUMOCYSTIS JIROVECII PNEUMONIA 108 0.0107
322 BLOOD CREATINE PHOSPHOKINASE INCREASED 308 0.0107
323 LUNG ADENOCARCINOMA 32 0.0106
324 BLOOD TRIGLYCERIDES INCREASED 184 0.0104
325 CYTOMEGALOVIRUS INFECTION 173 0.0104
326 FEMORAL NECK FRACTURE 53 0.0103
327 HYPERCHOLESTEROLAEMIA 99 0.0102
328 HEPATIC FUNCTION ABNORMAL 382 0.0102
329 HEPATITIS ACUTE 66 0.0101
330 NEPHROGENIC ANAEMIA 47 0.0101
331 FIBROSIS 31 0.0101
332 MYOPATHY 87 0.0101
333 CHOLELITHIASIS 328 0.0100
334 CHOLESTASIS 191 0.0099
335 RENAL FAILURE 1318 0.0099
336 STAPHYLOCOCCAL SEPSIS 49 0.0099
337 INTRACRANIAL PRESSURE INCREASED 55 0.0099
338 IMMUNODEFICIENCY 147 0.0099
339 PRESCRIBED OVERDOSE 190 0.0098
340 COELIAC DISEASE 96 0.0098
341 HEPATIC STEATOSIS 182 0.0098
342 DRUG TOXICITY 133 0.0098
343 BLOOD CREATINE INCREASED 43 0.0097
344 UMBILICAL HERNIA 45 0.0096
345 ANOREXIA 124 0.0096
346 DERMATITIS EXFOLIATIVE 48 0.0096
347 HERPES VIRUS INFECTION 55 0.0095
348 EXPOSURE VIA BREAST MILK 38 0.0095
349 AUTOIMMUNE THYROIDITIS 36 0.0095
350 ELECTROENCEPHALOGRAM ABNORMAL 30 0.0095
351 METABOLIC DISORDER 55 0.0095
352 PATHOLOGICAL FRACTURE 48 0.0094
353 PRODUCT DOSE OMISSION IN ERROR 266 0.0094
354 HERPES SIMPLEX 61 0.0094
355 TOXIC EPIDERMAL NECROLYSIS 142 0.0093
356 AUTOIMMUNE HEPATITIS 65 0.0093
357 AUTOIMMUNE HAEMOLYTIC ANAEMIA 32 0.0093
358 BLOOD ALBUMIN DECREASED 74 0.0093
359 HYPOTONIA 93 0.0093
360 PARANOIA 160 0.0093
361 RASH MACULO-PAPULAR 206 0.0093
362 METABOLIC ACIDOSIS 296 0.0092
363 GASTROENTERITIS 132 0.0090
364 HAEMOLYTIC ANAEMIA 81 0.0090
365 HAND FRACTURE 64 0.0090
366 CANDIDIASIS 36 0.0090
367 ANAEMIA 1709 0.0090
368 NEUROLOGICAL SYMPTOM 51 0.0089
369 POLYNEUROPATHY 106 0.0088
370 APLASTIC ANAEMIA 46 0.0088
371 TOOTH LOSS 182 0.0088
372 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 65 0.0087
373 HEPATIC CYTOLYSIS 110 0.0086
374 HEPATIC ENZYME INCREASED 584 0.0086
375 TACHYPNOEA 116 0.0085
376 PANCYTOPENIA 471 0.0084
377 ATAXIA 100 0.0084
378 LYMPHOMA 130 0.0084
379 MULTI-ORGAN FAILURE 145 0.0084
380 BURSITIS 101 0.0083
381 LEUKOENCEPHALOPATHY 31 0.0083
382 RENAL FAILURE ACUTE 350 0.0082
383 CORONARY ARTERY STENOSIS 41 0.0081
384 FOOT FRACTURE 153 0.0081
385 DEPRESSION 1826 0.0080
386 DEVELOPMENTAL DELAY 72 0.0080
387 DISSEMINATED INTRAVASCULAR COAGULATION 111 0.0079
388 NEPHROTIC SYNDROME 54 0.0079
389 CEREBRAL ATROPHY 31 0.0078
390 LOW DENSITY LIPOPROTEIN INCREASED 60 0.0077
391 NECROSIS 43 0.0077
392 ENTEROCOCCAL INFECTION 37 0.0076
393 DIPLOPIA 198 0.0076
394 SPINAL COMPRESSION FRACTURE 63 0.0076
395 LEUKOPENIA 381 0.0076
396 ACIDOSIS 58 0.0076
397 RENAL INJURY 225 0.0076
398 SKELETAL INJURY 77 0.0074
399 EPSTEIN-BARR VIRUS INFECTION 46 0.0074
400 FAILURE TO THRIVE 38 0.0073
401 CYTOMEGALOVIRUS INFECTION REACTIVATION 32 0.0072
402 MENINGITIS 48 0.0072
403 BENIGN PROSTATIC HYPERPLASIA 37 0.0072
404 ADRENAL INSUFFICIENCY 86 0.0071
405 TIBIA FRACTURE 33 0.0070
406 LEFT VENTRICULAR DYSFUNCTION 47 0.0070
407 ABDOMINAL HERNIA 32 0.0070
408 BRONCHOPULMONARY ASPERGILLOSIS 54 0.0070
409 NEUROTOXICITY 122 0.0070
410 ILEUS PARALYTIC 31 0.0069
411 ANXIETY 1975 0.0069
412 BONE MARROW FAILURE 141 0.0069
413 PAPILLOEDEMA 31 0.0069
414 DRUG LEVEL INCREASED 113 0.0068
415 GLUCOSE TOLERANCE IMPAIRED 40 0.0068
416 PNEUMONIA BACTERIAL 62 0.0067
417 DRUG LEVEL BELOW THERAPEUTIC 37 0.0067
418 PRODUCT DOSE OMISSION ISSUE 1965 0.0067
419 RENAL CYST 53 0.0067
420 LIVER FUNCTION TEST ABNORMAL 194 0.0067
421 RIB FRACTURE 136 0.0066
422 EXERCISE TOLERANCE DECREASED 38 0.0066
423 ENCEPHALOPATHY 161 0.0065
424 THROMBOCYTOPENIA 726 0.0065
425 COAGULOPATHY 108 0.0065
426 NEPHROLITHIASIS 297 0.0065
427 TORSADE DE POINTES 50 0.0064
428 LIVER INJURY 156 0.0063
429 PROTHROMBIN TIME PROLONGED 38 0.0063
430 IMMUNE THROMBOCYTOPENIA 29 0.0063
431 MALABSORPTION 33 0.0063
432 HEPATOCELLULAR INJURY 89 0.0063
433 HEMIPLEGIA 52 0.0062
434 PYELONEPHRITIS 54 0.0062
435 LIVER DISORDER 276 0.0062
436 PURPURA 55 0.0062
437 NERVOUS SYSTEM DISORDER 194 0.0062
438 MALNUTRITION 69 0.0062
439 ANGINA UNSTABLE 40 0.0061
440 MYOSITIS 55 0.0061
441 HYPOKALAEMIA 280 0.0061
442 PANCREATITIS ACUTE 136 0.0060
443 TUBULOINTERSTITIAL NEPHRITIS 113 0.0060
444 HYPERKALAEMIA 211 0.0060
445 LUNG INFILTRATION 53 0.0060
446 GUILLAIN-BARRE SYNDROME 29 0.0060
447 CHOLANGITIS 37 0.0060
448 RESPIRATORY DISTRESS 164 0.0059
449 LYMPHOCYTE COUNT DECREASED 105 0.0059
450 KLEBSIELLA INFECTION 30 0.0059
451 ACUTE KIDNEY INJURY 901 0.0059
452 DERMATITIS ALLERGIC 74 0.0059
453 RALES 34 0.0058
454 WRIST FRACTURE 70 0.0058
455 NEUTROPENIA 793 0.0058
456 RHINITIS 47 0.0058
457 PANCREATITIS 308 0.0058
458 HYPOCALCAEMIA 109 0.0058
459 HYPERTRANSAMINASAEMIA 40 0.0057
460 HAEMOLYSIS 44 0.0057
461 IMMUNOSUPPRESSION 50 0.0057
462 SEPTIC SHOCK 245 0.0056
463 GRANULOCYTOPENIA 32 0.0056
464 MULTIPLE ORGAN DYSFUNCTION SYNDROME 159 0.0056
465 PYREXIA 1942 0.0056
466 RENAL FAILURE CHRONIC 43 0.0056
467 EYELID OEDEMA 65 0.0056
468 BRAIN OEDEMA 70 0.0055
469 VISUAL FIELD DEFECT 40 0.0055
470 ATRIOVENTRICULAR BLOCK COMPLETE 37 0.0055
471 AGRANULOCYTOSIS 102 0.0055
472 RENAL PAIN 58 0.0055
473 CHOLECYSTITIS ACUTE 31 0.0055
474 HYPERTHYROIDISM 79 0.0055
475 RENAL DISORDER 254 0.0054
476 ABDOMINAL TENDERNESS 27 0.0054
477 BACTERAEMIA 64 0.0054
478 HEMIPARESIS 91 0.0054
479 ACUTE MYOCARDIAL INFARCTION 158 0.0054
480 DRUG ERUPTION 94 0.0053
481 NYSTAGMUS 28 0.0053
482 DYSSTASIA 154 0.0053
483 ANURIA 45 0.0052
484 RHABDOMYOLYSIS 218 0.0052
485 DRUG LEVEL DECREASED 53 0.0052
486 ODYNOPHAGIA 31 0.0052
487 NEUTROPENIC SEPSIS 37 0.0052
488 BEHAVIOUR DISORDER 28 0.0052
489 HAEMATOTOXICITY 49 0.0052
490 MUSCLE ATROPHY 64 0.0050
491 INTENTIONAL DOSE OMISSION 144 0.0050
492 ANKLE FRACTURE 78 0.0050
493 FEBRILE NEUTROPENIA 331 0.0050
494 PLATELET COUNT INCREASED 65 0.0050
495 INTERVERTEBRAL DISC DEGENERATION 46 0.0050
496 BOWEL MOVEMENT IRREGULARITY 38 0.0050
497 DIABETES MELLITUS 378 0.0050
498 CARDIOMYOPATHY 73 0.0049
499 DIFFUSE LARGE B-CELL LYMPHOMA 38 0.0049
500 LYMPHOEDEMA 34 0.0049
501 EOSINOPHILIA 86 0.0049
502 SKIN LESION 134 0.0049
503 POLYURIA 40 0.0049
504 CHROMATURIA 110 0.0049
505 DERMATITIS BULLOUS 35 0.0048
506 CENTRAL NERVOUS SYSTEM LESION 66 0.0048
507 NEUROPATHY PERIPHERAL 455 0.0048
508 CARDIOMEGALY 58 0.0047
509 HAEMODIALYSIS 39 0.0046
510 CHOLECYSTITIS 55 0.0046
511 NEUTROPHIL COUNT DECREASED 187 0.0046
512 TOXIC SKIN ERUPTION 46 0.0046
513 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 78 0.0045
514 PSEUDOMONAS INFECTION 39 0.0045
515 CLOSTRIDIUM DIFFICILE COLITIS 48 0.0045
516 FACE OEDEMA 76 0.0045
517 GASTRITIS 118 0.0045
518 ACUTE RESPIRATORY DISTRESS SYNDROME 79 0.0045
519 PULMONARY HYPERTENSION 93 0.0045
520 SPINAL OSTEOARTHRITIS 39 0.0044
521 HYPERGLYCAEMIA 161 0.0044
522 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 39 0.0044
523 PLATELET COUNT DECREASED 467 0.0044
524 MAJOR DEPRESSION 32 0.0044
525 VASCULITIS 51 0.0044
526 APPETITE DISORDER 29 0.0044
527 FLANK PAIN 41 0.0044
528 INABILITY TO AFFORD MEDICATION 43 0.0043
529 SKIN HYPERPIGMENTATION 37 0.0043
530 SINUS TACHYCARDIA 61 0.0043
531 RASH ERYTHEMATOUS 205 0.0043
532 FRACTURE 81 0.0043
533 SKIN PLAQUE 36 0.0043
534 PALLOR 116 0.0043
535 PAPULE 30 0.0043
536 RESPIRATORY FAILURE 310 0.0042
537 DIALYSIS 60 0.0042
538 GRAND MAL CONVULSION 39 0.0042
539 UPPER GASTROINTESTINAL HAEMORRHAGE 71 0.0042
540 SEPSIS 469 0.0042
541 CONTRAINDICATED PRODUCT ADMINISTERED 127 0.0042
542 MYOCARDITIS 48 0.0042
543 DECREASED IMMUNE RESPONSIVENESS 41 0.0042
544 STATUS EPILEPTICUS 47 0.0042
545 MITRAL VALVE INCOMPETENCE 47 0.0041
546 COVID-19 PNEUMONIA 49 0.0041
547 RASH GENERALISED 107 0.0041
548 LYMPHOPENIA 58 0.0041
549 SUDDEN DEATH 43 0.0041
550 RESPIRATORY RATE INCREASED 36 0.0041
551 SPINAL FRACTURE 81 0.0040
552 ESCHERICHIA INFECTION 33 0.0040
553 CONJUNCTIVITIS 74 0.0040
554 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 38 0.0040
555 IMPAIRED WORK ABILITY 85 0.0040
556 GENERALISED OEDEMA 49 0.0040
557 ARTERIOSCLEROSIS 37 0.0039
558 DISEASE RECURRENCE 186 0.0039
559 ABSCESS 62 0.0039
560 BLOOD UREA INCREASED 65 0.0039
561 HAEMATEMESIS 98 0.0039
562 ERYTHEMA MULTIFORME 36 0.0039
563 UPPER RESPIRATORY TRACT INFECTION 177 0.0038
564 BLOOD MAGNESIUM DECREASED 33 0.0038
565 HYPONATRAEMIA 215 0.0038
566 HAEMOGLOBIN DECREASED 390 0.0038
567 DRUG SCREEN POSITIVE 30 0.0038
568 BONE PAIN 222 0.0038
569 ACUTE CORONARY SYNDROME 31 0.0037
570 PRODUCT COMMUNICATION ISSUE 33 0.0037
571 LIVER FUNCTION TEST INCREASED 80 0.0037
572 HYPERCALCAEMIA 46 0.0037
573 PNEUMOTHORAX 59 0.0037
574 PERICARDIAL EFFUSION 86 0.0037
575 IMMUNE SYSTEM DISORDER 49 0.0037
576 GENERAL PHYSICAL HEALTH DETERIORATION 427 0.0037
577 NIGHTMARE 127 0.0037
578 SUICIDAL IDEATION 335 0.0037
579 VENTRICULAR EXTRASYSTOLES 38 0.0037
580 TRICUSPID VALVE INCOMPETENCE 29 0.0036
581 TENDERNESS 38 0.0036
582 ACUTE RESPIRATORY FAILURE 70 0.0036
583 PAIN 2230 0.0036
584 PHARYNGITIS 45 0.0036
585 NO THERAPEUTIC RESPONSE 44 0.0036
586 MUCOSAL INFLAMMATION 94 0.0036
587 PARKINSONISM 35 0.0036
588 ELECTROCARDIOGRAM QT PROLONGED 129 0.0036
589 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 92 0.0036
590 BONE DISORDER 65 0.0036
591 HAEMATURIA 122 0.0036
592 BLOOD SODIUM DECREASED 67 0.0036
593 CANDIDA INFECTION 60 0.0035
594 ERECTILE DYSFUNCTION 91 0.0035
595 CYTOKINE RELEASE SYNDROME 71 0.0035
596 UVEITIS 48 0.0035
597 ELECTROLYTE IMBALANCE 41 0.0035
598 ABNORMAL DREAMS 97 0.0035
599 BACTERIAL INFECTION 65 0.0035
600 PLEURAL EFFUSION 211 0.0035
601 METASTASES TO LUNG 40 0.0035
602 HYPERTENSION 729 0.0034
603 ABDOMINAL DISTENSION 359 0.0034
604 APPENDICITIS 32 0.0034
605 DYSPHAGIA 323 0.0034
606 FACIAL PARALYSIS 29 0.0034
607 GOUT 61 0.0034
608 CONDITION AGGRAVATED 1027 0.0034
609 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 176 0.0034
610 TOOTH FRACTURE 37 0.0034
611 WHITE BLOOD CELL COUNT DECREASED 362 0.0033
612 GASTROINTESTINAL DISORDER 299 0.0033
613 ULCER 53 0.0033
614 URINE OUTPUT DECREASED 29 0.0033
615 SQUAMOUS CELL CARCINOMA 31 0.0033
616 BLOOD CALCIUM DECREASED 37 0.0033
617 OEDEMA PERIPHERAL 400 0.0033
618 HAEMATOCRIT DECREASED 65 0.0033
619 MOBILITY DECREASED 235 0.0033
620 GYNAECOMASTIA 101 0.0033
621 MENTAL STATUS CHANGES 90 0.0032
622 HYPOXIA 114 0.0032
623 PARALYSIS 46 0.0032
624 SUBDURAL HAEMATOMA 46 0.0032
625 LUNG NEOPLASM MALIGNANT 132 0.0032
626 DIARRHOEA HAEMORRHAGIC 30 0.0032
627 MENTAL DISORDER 139 0.0032
628 VOMITING 1500 0.0032
629 REBOUND EFFECT 36 0.0032
630 GASTRIC ULCER 60 0.0032
631 VIRAL INFECTION 105 0.0032
632 ABDOMINAL PAIN 734 0.0032
633 CORONARY ARTERY DISEASE 95 0.0031
634 C-REACTIVE PROTEIN INCREASED 114 0.0031
635 DRUG INTOLERANCE 302 0.0031
636 OESOPHAGITIS 34 0.0031
637 CYTOPENIA 38 0.0031
638 SPINAL PAIN 36 0.0031
639 LOWER LIMB FRACTURE 59 0.0031
640 PRODUCT USE ISSUE 574 0.0031
641 FLUID RETENTION 155 0.0030
642 MOTOR DYSFUNCTION 31 0.0030
643 CONVULSION 173 0.0030
644 GASTROOESOPHAGEAL REFLUX DISEASE 243 0.0030
645 ASTHENIA 1135 0.0030
646 AFFECT LABILITY 29 0.0030
647 BLOOD CHOLESTEROL INCREASED 140 0.0030
648 PNEUMONIA 970 0.0030
649 PRODUCT USE COMPLAINT 47 0.0030
650 STAPHYLOCOCCAL INFECTION 98 0.0030
651 ANGINA PECTORIS 85 0.0030
652 SHOCK 68 0.0030
653 OEDEMA 160 0.0029
654 HYPOMAGNESAEMIA 41 0.0029
655 BODY TEMPERATURE INCREASED 60 0.0029
656 DELIRIUM 102 0.0029
657 HELICOBACTER INFECTION 30 0.0029
658 TYPE 2 DIABETES MELLITUS 98 0.0029
659 DEAFNESS 76 0.0029
660 RASH PAPULAR 65 0.0029
661 HERPES ZOSTER 166 0.0029
662 DYSURIA 106 0.0029
663 NERVE INJURY 32 0.0029
664 THERAPY NON-RESPONDER 129 0.0029
665 DYSPNOEA EXERTIONAL 108 0.0029
666 GAIT DISTURBANCE 548 0.0029
667 INCONTINENCE 30 0.0028
668 WEIGHT DECREASED 791 0.0028
669 NEUTROPHIL COUNT INCREASED 29 0.0028
670 DEPRESSED LEVEL OF CONSCIOUSNESS 112 0.0028
671 VISUAL ACUITY REDUCED 94 0.0028
672 POLLAKIURIA 118 0.0028
673 MYALGIA 479 0.0028
674 MOUTH ULCERATION 59 0.0028
675 MASS 39 0.0028
676 VENTRICULAR TACHYCARDIA 46 0.0028
677 LUNG INFECTION 43 0.0028
678 INTERSTITIAL LUNG DISEASE 134 0.0028
679 ACUTE MYELOID LEUKAEMIA 43 0.0028
680 PRODUCT DOSE OMISSION 180 0.0028
681 SKIN ULCER 71 0.0027
682 CEREBRAL INFARCTION 67 0.0027
683 INTENTIONAL PRODUCT USE ISSUE 240 0.0027
684 CYANOSIS 43 0.0027
685 GENERALISED TONIC-CLONIC SEIZURE 45 0.0027
686 OSTEOARTHRITIS 115 0.0027
687 UPPER LIMB FRACTURE 54 0.0027
688 BLOOD POTASSIUM INCREASED 44 0.0027
689 DEPRESSED MOOD 143 0.0027
690 CARDIAC FAILURE 217 0.0027
691 MYELOSUPPRESSION 97 0.0027
692 PULMONARY MASS 40 0.0027
693 HIP ARTHROPLASTY 41 0.0027
694 TACHYCARDIA 237 0.0027
695 DYSARTHRIA 100 0.0027
696 NOCTURIA 32 0.0026
697 MELAENA 58 0.0026
698 INFLAMMATION 136 0.0026
699 LUNG DISORDER 129 0.0026
700 VENTRICULAR FIBRILLATION 29 0.0026
701 LABORATORY TEST ABNORMAL 77 0.0026
702 SLEEP DISORDER 183 0.0026
703 TENDONITIS 40 0.0026
704 HALLUCINATION, AUDITORY 41 0.0026
705 NIGHT SWEATS 83 0.0026
706 CEREBRAL HAEMORRHAGE 92 0.0026
707 LETHARGY 147 0.0026
708 DISORIENTATION 101 0.0025
709 LEUKOCYTOSIS 46 0.0025
710 DECREASED APPETITE 587 0.0025
711 NEOPLASM 29 0.0025
712 EPILEPSY 77 0.0025
713 HYPOTHYROIDISM 80 0.0025
714 RASH 1091 0.0025
715 ILEUS 31 0.0025
716 ALTERED STATE OF CONSCIOUSNESS 54 0.0025
717 HYPOKINESIA 36 0.0025
718 NEURALGIA 60 0.0025
719 BLOOD PRESSURE SYSTOLIC INCREASED 48 0.0025
720 INSOMNIA 651 0.0024
721 COORDINATION ABNORMAL 34 0.0024
722 DIARRHOEA 1571 0.0024
723 INTERVERTEBRAL DISC PROTRUSION 53 0.0024
724 FEAR 65 0.0024
725 RED BLOOD CELL COUNT DECREASED 69 0.0024
726 CORONARY ARTERY OCCLUSION 33 0.0024
727 MUSCULOSKELETAL CHEST PAIN 37 0.0024
728 NAUSEA 1890 0.0024
729 BLINDNESS 97 0.0024
730 RESPIRATORY TRACT INFECTION 62 0.0024
731 HYPERSENSITIVITY 441 0.0024
732 BACK PAIN 551 0.0024
733 HAEMOPTYSIS 66 0.0024
734 CHILLS 277 0.0024
735 CIRCULATORY COLLAPSE 40 0.0023
736 WHEEZING 139 0.0023
737 APATHY 34 0.0023
738 COMA 111 0.0023
739 MUSCULAR WEAKNESS 263 0.0023
740 HYPOPHAGIA 59 0.0023
741 FEMUR FRACTURE 71 0.0023
742 HOSPITALISATION 352 0.0023
743 PNEUMONITIS 62 0.0023
744 GASTROINTESTINAL HAEMORRHAGE 190 0.0023
745 PERITONITIS 47 0.0023
746 EATING DISORDER 48 0.0023
747 APHASIA 68 0.0022
748 HEPATIC CANCER 54 0.0022
749 HYPERHIDROSIS 289 0.0022
750 INFUSION RELATED REACTION 148 0.0022
751 NODULE 29 0.0022
752 INFECTION 321 0.0022
753 DEHYDRATION 294 0.0022
754 PERICARDITIS 37 0.0022
755 RESTLESSNESS 80 0.0022
756 HIP FRACTURE 70 0.0022
757 BLOOD POTASSIUM DECREASED 65 0.0022
758 DERMATITIS 45 0.0021
759 INTENTIONAL PRODUCT MISUSE 188 0.0021
760 PULMONARY ARTERIAL HYPERTENSION 31 0.0021
761 COLITIS 81 0.0021
762 OBESITY 34 0.0021
763 RASH PRURITIC 115 0.0021
764 MOVEMENT DISORDER 68 0.0021
765 DISTURBANCE IN ATTENTION 114 0.0021
766 ILL-DEFINED DISORDER 128 0.0021
767 RESPIRATORY DISORDER 63 0.0021
768 INTERNATIONAL NORMALISED RATIO INCREASED 60 0.0021
769 MUSCULOSKELETAL DISORDER 40 0.0021
770 PULMONARY OEDEMA 94 0.0021
771 TOXICITY TO VARIOUS AGENTS 353 0.0021
772 DEEP VEIN THROMBOSIS 136 0.0021
773 ISCHAEMIC STROKE 37 0.0021
774 SKIN DISORDER 69 0.0021
775 CONFUSIONAL STATE 333 0.0021
776 ADVERSE DRUG REACTION 185 0.0021
777 PNEUMONIA ASPIRATION 51 0.0020
778 PERIPHERAL COLDNESS 28 0.0020
779 DIABETES MELLITUS INADEQUATE CONTROL 36 0.0020
780 PHOTOPHOBIA 38 0.0020
781 MYOCARDIAL INFARCTION 351 0.0020
782 HYPOAESTHESIA 301 0.0020
783 PALPITATIONS 235 0.0020
784 FATIGUE 1561 0.0020
785 COGNITIVE DISORDER 93 0.0020
786 DISEASE PROGRESSION 235 0.0020
787 VERTIGO 120 0.0020
788 PULMONARY EMBOLISM 187 0.0020
789 COUGH 547 0.0019
790 WEIGHT INCREASED 436 0.0019
791 SUICIDE ATTEMPT 118 0.0019
792 MANIA 32 0.0019
793 HAEMORRHAGE INTRACRANIAL 29 0.0019
794 BLINDNESS UNILATERAL 27 0.0019
795 ABASIA 47 0.0019
796 ARRHYTHMIA 90 0.0019
797 SEROTONIN SYNDROME 36 0.0019
798 HYPOTENSION 374 0.0019
799 RASH MACULAR 65 0.0019
800 WHITE BLOOD CELL COUNT INCREASED 71 0.0018
801 CHEST PAIN 342 0.0018
802 PLASMA CELL MYELOMA 72 0.0018
803 PRODUCTIVE COUGH 88 0.0018
804 HYPOGLYCAEMIA 89 0.0018
805 HEADACHE 1148 0.0018
806 SWELLING FACE 119 0.0018
807 AMENORRHOEA 32 0.0018
808 FEEDING DISORDER 37 0.0018
809 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 327 0.0018
810 PRODUCT DISPENSING ERROR 39 0.0018
811 DIABETIC KETOACIDOSIS 43 0.0018
812 GLYCOSYLATED HAEMOGLOBIN INCREASED 45 0.0018
813 MALAISE 777 0.0018
814 PHOTOSENSITIVITY REACTION 29 0.0018
815 NEOPLASM PROGRESSION 61 0.0018
816 FAECES DISCOLOURED 38 0.0018
817 CELLULITIS 88 0.0017
818 IRRITABILITY 105 0.0017
819 HAEMORRHOIDS 34 0.0017
820 BLOOD URINE PRESENT 33 0.0017
821 MOOD ALTERED 47 0.0017
822 POOR QUALITY SLEEP 37 0.0017
823 ANGIOEDEMA 76 0.0017
824 HALLUCINATION 129 0.0017
825 CARDIAC ARREST 141 0.0017
826 BRADYCARDIA 90 0.0017
827 ABNORMAL BEHAVIOUR 67 0.0017
828 PRODUCT USE IN UNAPPROVED INDICATION 415 0.0017
829 SYNOVITIS 30 0.0017
830 AGITATION 122 0.0017
831 HALLUCINATION, VISUAL 35 0.0017
832 URINARY INCONTINENCE 49 0.0017
833 PANIC ATTACK 60 0.0016
834 GAIT INABILITY 55 0.0016
835 METRORRHAGIA 28 0.0016
836 ABDOMINAL PAIN UPPER 338 0.0016
837 ARTHRALGIA 682 0.0016
838 ACCIDENTAL OVERDOSE 60 0.0016
839 OFF LABEL USE 1436 0.0016
840 AGGRESSION 82 0.0016
841 PRURITUS GENERALISED 35 0.0016
842 CARDIOVASCULAR DISORDER 41 0.0016
843 EYE DISORDER 53 0.0016
844 ASTHMA 180 0.0016
845 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 37 0.0016
846 SPEECH DISORDER 83 0.0016
847 AMNESIA 103 0.0016
848 PAIN IN EXTREMITY 465 0.0016
849 SKIN DISCOLOURATION 72 0.0016
850 DEATH 1342 0.0016
851 JOINT SWELLING 188 0.0016
852 STOMATITIS 94 0.0015
853 SOMNOLENCE 312 0.0015
854 INTESTINAL OBSTRUCTION 58 0.0015
855 CONSTIPATION 334 0.0015
856 DISCOMFORT 93 0.0015
857 DYSPNOEA 858 0.0015
858 DIZZINESS 755 0.0015
859 LOSS OF CONSCIOUSNESS 193 0.0015
860 ABDOMINAL PAIN LOWER 38 0.0015
861 RETCHING 32 0.0015
862 URINARY TRACT INFECTION 255 0.0015
863 EXTRA DOSE ADMINISTERED 60 0.0015
864 ATRIAL FIBRILLATION 144 0.0015
865 SKIN EXFOLIATION 124 0.0015
866 FLATULENCE 83 0.0015
867 PARAESTHESIA 229 0.0015
868 ADVERSE EVENT 134 0.0015
869 GLAUCOMA 28 0.0015
870 MUSCULOSKELETAL PAIN 76 0.0014
871 THERAPY CESSATION 73 0.0014
872 HAEMORRHAGE 148 0.0014
873 NEOPLASM MALIGNANT 94 0.0014
874 CHEST DISCOMFORT 144 0.0014
875 MENTAL IMPAIRMENT 34 0.0014
876 ERYTHEMA 288 0.0014
877 COVID-19 245 0.0014
878 CARDIAC FAILURE CONGESTIVE 111 0.0014
879 DRUG INEFFECTIVE 1816 0.0014
880 OVERDOSE 296 0.0014
881 TINNITUS 63 0.0014
882 THERAPEUTIC RESPONSE DECREASED 83 0.0014
883 SEIZURE 158 0.0014
884 ROAD TRAFFIC ACCIDENT 57 0.0014
885 HAEMATOCHEZIA 75 0.0014
886 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 96 0.0013
887 URINARY RETENTION 45 0.0013
888 DYSPEPSIA 131 0.0013
889 ABDOMINAL DISCOMFORT 223 0.0013
890 EPISTAXIS 99 0.0013
891 LOWER RESPIRATORY TRACT INFECTION 60 0.0013
892 HAEMATOMA 34 0.0013
893 BLISTER 73 0.0013
894 BRONCHITIS 96 0.0013
895 BLOOD PRESSURE DECREASED 86 0.0013
896 SYNCOPE 128 0.0013
897 UNRESPONSIVE TO STIMULI 33 0.0013
898 MUSCULOSKELETAL STIFFNESS 112 0.0013
899 RHEUMATOID ARTHRITIS 145 0.0013
900 PRESYNCOPE 31 0.0013
901 CARDIO-RESPIRATORY ARREST 53 0.0013
902 NECK PAIN 70 0.0013
903 PRURITUS 478 0.0012
904 RECTAL HAEMORRHAGE 53 0.0012
905 OROPHARYNGEAL PAIN 114 0.0012
906 FUNGAL INFECTION 41 0.0012
907 CRYING 44 0.0012
908 DYSKINESIA 49 0.0012
909 OXYGEN SATURATION DECREASED 67 0.0012
910 TREMOR 197 0.0012
911 ARTHRITIS 92 0.0012
912 GASTRIC DISORDER 40 0.0012
913 PSORIASIS 151 0.0012
914 MEDICATION ERROR 64 0.0012
915 ILLNESS 118 0.0011
916 CEREBROVASCULAR ACCIDENT 194 0.0011
917 MUSCLE SPASMS 206 0.0011
918 VISION BLURRED 153 0.0011
919 FEELING COLD 31 0.0011
920 DEMENTIA 31 0.0011
921 MEMORY IMPAIRMENT 152 0.0011
922 THROMBOSIS 89 0.0011
923 HYPERSOMNIA 31 0.0011
924 HEART RATE INCREASED 106 0.0011
925 TRANSIENT ISCHAEMIC ATTACK 36 0.0011
926 FALL 349 0.0010
927 CARDIAC DISORDER 98 0.0010
928 BALANCE DISORDER 90 0.0010
929 BLOOD PRESSURE INCREASED 157 0.0010
930 EYE SWELLING 38 0.0010
931 URTICARIA 171 0.0010
932 NO ADVERSE EVENT 183 0.0010
933 DRUG ABUSE 83 0.0010
934 INFLUENZA LIKE ILLNESS 82 0.0010
935 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54 0.0010
936 SWELLING 92 0.0010
937 HEAD INJURY 31 0.0010
938 CATARACT 58 0.0010
939 PRODUCT STORAGE ERROR 85 0.0010
940 RHINORRHOEA 62 0.0010
941 INFLUENZA 106 0.0009
942 HYPOACUSIS 40 0.0009
943 OCULAR HYPERAEMIA 44 0.0009
944 DRUG DOSE OMISSION 152 0.0009
945 ANGER 31 0.0009
946 CONTUSION 88 0.0009
947 ALOPECIA 179 0.0009
948 INJURY 64 0.0009
949 ECZEMA 47 0.0009
950 DRY MOUTH 72 0.0009
951 EYE PAIN 50 0.0009
952 PERIPHERAL SWELLING 136 0.0009
953 MOOD SWINGS 28 0.0009
954 VAGINAL HAEMORRHAGE 38 0.0009
955 SURGERY 51 0.0009
956 THERAPEUTIC RESPONSE UNEXPECTED 39 0.0009
957 MALIGNANT NEOPLASM PROGRESSION 89 0.0009
958 PRODUCT SUBSTITUTION ISSUE 50 0.0009
959 NERVOUSNESS 45 0.0009
960 BLOOD GLUCOSE INCREASED 162 0.0009
961 DYSPHONIA 50 0.0009
962 NASAL CONGESTION 50 0.0008
963 FEELING HOT 52 0.0008
964 DYSGEUSIA 61 0.0008
965 UNEVALUABLE EVENT 62 0.0008
966 BURNING SENSATION 57 0.0008
967 THERAPY INTERRUPTED 57 0.0008
968 INTENTIONAL OVERDOSE 51 0.0008
969 FEELING ABNORMAL 188 0.0008
970 THERAPEUTIC PRODUCT EFFECT DECREASED 35 0.0008
971 INCORRECT DOSE ADMINISTERED 169 0.0007
972 SINUSITIS 74 0.0007
973 ARTHROPATHY 39 0.0007
974 DRY EYE 35 0.0007
975 NASOPHARYNGITIS 128 0.0007
976 MIGRAINE 64 0.0007
977 DRY SKIN 87 0.0007
978 THROAT IRRITATION 29 0.0006
979 VISUAL IMPAIRMENT 78 0.0006
980 COMPLETED SUICIDE 52 0.0006
981 FLUSHING 62 0.0006
982 BLOOD GLUCOSE DECREASED 28 0.0006
983 UNDERDOSE 40 0.0005
984 ANAPHYLACTIC REACTION 30 0.0005
985 ACNE 41 0.0005
986 DRUG EFFECT DECREASED 28 0.0005
987 HOT FLUSH 38 0.0005
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 94 0.0005
989 PROSTATE CANCER 35 0.0004
990 INJECTION SITE REACTION 29 0.0004
991 PRODUCT QUALITY ISSUE 46 0.0003
992 INJECTION SITE PAIN 75 0.0002